IL6 and Insulin resistance: Insulin resistance is associated with a state of chronic low-grade inflammation, and mediators such as tumor necrosis factor-α (TNF-α), interleukin 1beta (IL-1β), and interleukin-6 (IL-6) have been identified as being involved in metabolic control and impairment in insulin-receptor signaling [17].